Safety of leukoreduced, cytomegalovirus (CMV)-untested components in CMV-negative allogeneic human progenitor cell transplant recipients

被引：27
|
作者：
Nash, Tammon [1 ]
Hoffmann, Sandra [2 ]
Butch, Suzanne [2 ]
Davenport, Robertson [2 ]
Cooling, Laura [2 ]
机构：
[1] Michigan Blood, Grand Rapids, MI USA
[2] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
来源：
TRANSFUSION | 2012年 / 52卷 / 10期
关键词：
BLOOD-PRODUCTS; TRANSFUSION; TRANSMISSION; INFECTION;
D O I：
10.1111/j.1537-2995.2012.03739.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2270 / 2272
页数：3
相关论文
共 50 条
  • [31] Impact of Cytomegalovirus (CMV) Viral Load on Probability of Spontaneous Clearance and Efficacy of Pre-Emptive Therapy Among CMV Seropositive Allogeneic Stem Cell Transplant Recipients
    Camargo, Jose F.
    Shimose, Luis
    Bueno, Maria X.
    Rosa, Rossana
    Jeyakumar, Nikeshan
    Morris, Michele I.
    Abbo, Lilian M.
    Simkins, Jacques
    Alencar, Maritza C.
    Benjamin, Cara L.
    Wieder, Eric
    Kimble, Erik L.
    Jimenez, Antonio M.
    Beitinjaneh, Amer
    Goodman, Mark
    Byrnes, John J.
    Lekakis, Lazaros
    Pereira, Denise
    Komanduri, Krishna V.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S175 - S176
  • [32] Relationship of Reconstituted Adaptive and Innate Cytomegalovirus (CMV)-Specific Immune Responses with CMV Viremia in Hematopoietic Stem Cell Transplant Recipients
    Barron, Michelle A.
    Gao, Dexiang
    Springer, Kathryn L.
    Patterson, Julie A.
    Brunvand, Mark W.
    McSweeney, Peter A.
    Zeng, Chang
    Baron, Anna E.
    Weinberg, Adriana
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (12) : 1777 - 1783
  • [33] EVALUATION OF HUMAN CYTOMEGALOVIRUS (CMV) SPECIFIC T-CELL RESPONSES PREDICTS EARLY AND LATE ONSET CMV INFECTION IN A COHORT OF KIDNEY TRANSPLANT RECIPIENTS
    Pierobon, Elisa S.
    Furian, Lucrezia
    Silvestre, Cristina
    Bonfante, Luciana
    Rossi, Barbara
    Marchini, Francesco
    Fiscon, Marta
    Saldan, Alda
    Barzon, Luisa
    Sgarabotto, Dino
    Abate, Davide
    Palu, Giorgio
    Rigotti, Paolo
    TRANSPLANT INTERNATIONAL, 2011, 24 : 280 - 280
  • [34] Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status
    Servais, S.
    Dumontier, N.
    Biard, L.
    Schnepf, N.
    Resche-Rigon, M.
    de Latour, R. Peffault
    Scieux, C.
    Robin, M.
    Meunier, M.
    Xhaard, A.
    de Fontbrune, F. Sicre
    Le Goff, J.
    Socie, G.
    Simon, F.
    Mazeron, M. -C.
    CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (03) : 289.e1 - 289.e7
  • [35] Detection and pharmacokinetics of a cytomegalovirus (CMV) DNA plasmid in human plasma during a clinical trial of an intramuscular CMV vaccine in hematopoietic stem cell transplant recipients
    Salimnia, H.
    Fairfax, M. R.
    Chandrasekar, P. H.
    TRANSPLANT INFECTIOUS DISEASE, 2014, 16 (06) : 914 - 918
  • [36] Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients
    Limaye, AP
    Huang, ML
    Leisenring, W
    Stensland, L
    Corey, L
    Boeckh, M
    JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (03): : 377 - 382
  • [37] Cidofovir for treatment of CMV and adenovirus infections in allogeneic stem cell transplant recipients.
    Ljungman, P
    Deliliers, GL
    Ribaud, P
    Einsele, H
    Ullmann, J
    Musso, M
    Trenschel, R
    Platzbecker, U
    Bacigalupo, A
    Bosi, A
    Cesaro, S
    Crooks, B
    Dekker, A
    Gratecos, N
    Klingebiel, T
    Tagliaferri, E
    Wacker, P
    Cordonnier, C
    BLOOD, 1999, 94 (10) : 396A - 396A
  • [38] Influence of Donor Cytomegalovirus (CMV) Status on Severity of Viral Reactivation after Allogeneic Stem Cell Transplantation in CMV-Seropositive Recipients
    Pietersma, Floor L.
    van Dorp, Suzanne
    Minnema, Monique C.
    Kuball, Jurgen
    Meijer, Ellen
    Schuurman, Rob
    van Baarle, Debbie
    CLINICAL INFECTIOUS DISEASES, 2011, 52 (07) : E144 - E148
  • [39] Efficacy and Pharmacoeconomic Impact of Letermovir for CMV Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients
    Merchant, Shelby Lorraine
    Gatwood, Katie S.
    Satyanarayana, Gowri
    Byrne, Michael T.
    Kassim, Adetola A.
    Jagasia, Madan
    Savani, Bipin
    Engelhardt, Brian G.
    Culos, Kathryn Ann A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [40] Cost Effectiveness of Letermovir in Prevention of Clinically Significant CMV Infection in CMV Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (04) : 12 - 13
12345